ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0RAM Vistin Pharma Asa

11.25
0.00 (0.00%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vistin Pharma Asa LSE:0RAM London Ordinary Share NO0010734122 VISTIN PHARMA ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 438.33M 45.64M 1.0293 10.93 498.88M

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

30/04/2024 7:58am

UK Regulatory


Vistin Pharma Asa (LSE:0RAM)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more Vistin Pharma Asa Charts.
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

Oslo, Norway, 30 April 2024

Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST.

A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.

The recommendation from the Election Committee is available on the Company's website. The formal call will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and are also attached to this announcement.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

 

 

Attachments

  • Vistinpharmaasa-2023-12-31-en
  • 2023 Annual Report Vistin Pharma ASA
  • Proposal Election committee Vistin ASA for AGM 2024 signed
  • Remuneration policy for salary and other remuration for executive management and board members
  • Call for annual general meeting 23 May 2024

1 Year Vistin Pharma Asa Chart

1 Year Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

1 Month Vistin Pharma Asa Chart

Your Recent History

Delayed Upgrade Clock